Identification of serum biomarkers for colon cancer by proteomic analysis

British Journal of Cancer

Volumn 94, Issue 12, 2006, Pages 1898-1905

  Ward, D G ^a   Suggett, N ^a,b   Cheng, Y ^a   Wei, W ^a   Johnson, H ^a   Billingham, L J ^a   Ismail, T ^a,b   Wakelam, M J O ^a   Johnson, P J ^a   Martin, A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Biomarker; Colorectal cancer; Mass spectrometry; Proteomic; SELDI; Serum proteome

Indexed keywords

ALPHA 1 ANTITRYPSIN; BIOLOGICAL MARKER; COMPLEMENT COMPONENT C3A; TRANSFERRIN;

ADULT; AGED; ARTICLE; ARTIFICIAL NEURAL NETWORK; CANCER DIAGNOSIS; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROTEOMICS; SURFACE ENHANCED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;

ADENOCARCINOMA; AGED; BLOTTING, WESTERN; CARCINOEMBRYONIC ANTIGEN; COLONIC NEOPLASMS; FEMALE; HEMATOLOGIC TESTS; HUMANS; MALE; PROTEOMICS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 33745085581     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603188     Document Type: Article

References (36)

1. Adam B-L, Qu YQ, Davis JW, Ward MD, Clements MA, Cazares LH, Semmes OJ, Schellhammer PF, Yasui Y, Feng Z, Wright jnr GL (2002) Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62: 3609-3614
2. Ahlquist DA, Skoletsky JE, Boynton KA, Harrington JJ, Mahoney DW, Pierceall WE, Thibodeau SN, Shuber AP (2000) Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay panel. Gastroenterology 119: 1219-1227
3. Banez LL, Prasanna P, Sun L, Ali A, Zou Z, Adam BL, McCleod DG, Moul JW, Srivastava S (2003) Diagnostic potential of serum proteomic patterns in prostate cancer. J Urol 170: 442-446
4. Bondarenko PV, Cockrill SL, Watkins LK, Cruzado ID, Macfarlane RD (1999) Mass spectral study of polymorphism of the apolipoproteins of very low density lipoprotein. JLipid Res 40: 543-555
5. Chen Y, Zheng S, Yu J-K, Hu X (2004) Artificial neural networks analysis of surface-enhanced laser desorption/ionisation mass spectra of serum protein pattern distinguishes colorectal cancer from healthy population. Clin Cancer Res 10: 8380-8385
6. CRUK (2004) Cancer Stats - Survival. England and Wales:Cancer Research UK, www.cancerresearchuk.org
7. Dong SM, Traverso G, Johnson C, Geng L, Favis R, Boynton K, Hibi K, Goodman S, D'Allessio M, Paty P, Hamilton S, Sidransky D, Barany F, Levin B, Shuber A, Kinzler K, Vogelstein B, Jen J (2001) Detecting colorectal cancer in stool with the use of multiple genetic targets. J Natl Cancer Inst 93: 858-865
8. Fletcher RH (1986) Carcinoembryonic antigen. Ann Intern Med 104: 66-73
9. Greenlee R, Hill-Harmon MB, Murray T, Thun M (2001) Cancer statistics, 2001. Cancer J Clin 51: 15-36
10. Guang Z, Chun-Fang G, Guo-Ying S, Dong-Hui L, Xiu-Li W (2004) Identification of colorectal cancer using proteomic patters in serum. Chin J Cancer 23: 614-618
11. Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James P, Balfour T, Amar S, Armitage N, Moss S (1989) Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107 349 subjects. Lancet 1: 1160-1164
12. Jackman RJ, Mayo CW (1951) The adenoma - carcinoma sequence in cancer of the colon. Surg Gynecol Obstet 93: 327-330
13. Koomen JM, Shih LN, Coombes KR, Li D, Xiao L-C, Fidler IJ, Abbruzzese JL, Kobayashi R (2005) Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. Clin Cancer Res 11: 1110-1118
14. Kozak KR, Amneua MW, Pusey SM, AL E (2003) Identification of biomarkers for ovarian cancer using strong anion-exchange protein-chips: potential use in diagnosis and prognosis. Proc Natl Acad Sci USA 100: 12343-12348
15. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O (1996) Randomised study of screening for colorectal cancer with faecal-occult blood test. Lancet 348: 1467-1471
16. Le L, Chi K, Tyldesley S, Flibotte S, Diamond D, Kuzyk M, Sadar M (2005) Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem 51: 695-707
17. Li J, Rosenzweig JM, Wang YY, Chan DW (2002) Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. Clin Chem 48: 1296-1304
18. Mainous AG, Gill JM, Everett CJ (2005) Transferrin saturation, dietry iron intake, and risk of cancer. Ann Family Med 3: 131-137
19. Malik G, Ward MD, Gupta SK, Trosset MW, Grizzle WE, Adam B-L, Diaz JI, Semmes OJ (2005) Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. Clin Cancer Res 11: 1073-1085
20. Mandel JS, Bond JH, Church TR, Snover D, Bradley G, Schuman L, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med 328: 1365-1371
21. Mollnes TE, Garred P, Bergseth G (1988) Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. Clin Exp Immunol 73: 484-488
22. Muller AD, Sonnenberg A (1995) Prevention of colorectal cancer by flexible endoscopy and polypectomy. A case control study of 32 702 veterans. Ann Intern Med 123: 904-910
23. Nelson RL (2001) Iron and colorectal cancer risk: human studies. Nutr Rev 59: 140-148
24. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM (1992) Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 84: 1572-1575
25. Paradis V, Degos F, Dargere D, Pham N, Belghiti J, Degott C, Janeau J-L, Bezeaud A, Delforge D, Cubizolles M, Laurendeau I, Bedossa P (2005) Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver disease. Hepatology 41: 40-47
26. Petricoin EF, Ardekani AM, Hitt BA, Levine P, Fusaro V, Steinberg S, Mills G, Simone C, Fishman D, Kohn E, Liotta L (2002) Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-575
27. Poon TCW, Chan ATC, Zee B, Ho SKW, Mok TSK, Leung TWT, Johnson PJ (2001) Application of classification tree and neural network algorithms to the identification of serological liver marker profiles for the diagnosis of hepatocellular carcinoma. Oncology 61: 275-283
28. Poon TCW, Yip T-T, Chan ATC, Yip C, Yip V, Mok TSK, Lee CCY, Leung TWT, Ho SKW, Johnson PJ (2003) Comprehensive proteomic profiling identifies serum proteomic signatures for detection of hepatocellular carcinoma and its subtypes. Clin Chem 49: 752-760
29. Qu Y, Adam BL, Yasui Y, AL E (2002) Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from non-cancer patients. Clin Chem 48: 1835-1843
30. Ransohoff DF (2004) Rules of evidence for cancer molecular-marker discovery and validation. Nat Rev: Cancer 4: 309-313
31. Selby JV, Friedman GD, Quesenberry CP, Weiss NS (1992) A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 326: 653-657
32. Tierney RP, Ballantyne GH, Modlin IM (1990) The adenoma to carcinoma sequence. Surg Gynecol Obstet 171: 81-94
33. Vlahou A, Schellhammer PF, Mendrinos S, Patel K, Kondylis F, Gong L, Nasim S, Wright GJ (2001) Development of a novel proteomic approach for the detection of transitional cell carcinoma of the bladder in urine. Am J Pathol 158: 1491-1502
34. Ward DG, Chen YC, N'Kontchou G, Thar TT, Barget N, Wei W, Billingham LJ, Martin A, Beaugrand M, Johnson P (2006) HCC induced changes in the serum proteome of hepatitis C infected chronic liver disease patients. Br J Cancer 94(2): 287-292
35. Weinberg ED (1994) Association of iron with colorectal cancer. Biometals 7: 211-216
36. Yu J-K, Chen Y-D, Zheng S (2004) An integrated approach to the detection of colorectal cancer utilizing proteomics and bioinformatics. World J Gastroenterol 10: 3127-3131